OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages
Katja Hönzke, Benedikt Obermayer, Christin Mache, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 6, pp. 2102725-2102725
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Comorbidities, multimorbidity and COVID-19
Clark D Russell, Nazir Lone, J. Kenneth Baillie
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 334-343
Open Access | Times Cited: 257

Distinct tissue niches direct lung immunopathology via CCL18 and CCL21 in severe COVID-19
Ronja Mothes, Anna Pascual Reguant, Ralf Koehler, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 34

Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation
Obdulio García-Nicolás, Aurélie Godel, Gert Zimmer, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 835-849
Open Access | Times Cited: 24

Prolonged exposure to lung-derived cytokines is associated with activation of microglia in patients with COVID-19
Rogan A. Grant, Taylor A. Poor, Lango Sichizya, et al.
JCI Insight (2024)
Open Access | Times Cited: 12

Alveolar Macrophages in Viral Respiratory Infections: Sentinels and Saboteurs of Lung Defense
Pauline Pöpperl, Melanie Stoff, Andreas Beineke
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 407-407
Open Access | Times Cited: 1

Modulation of alveolar macrophage and mitochondrial fitness by medicinal plant-derived nanovesicles to mitigate acute lung injury and viral pneumonia
Lusha Ye, Yanan Gao, Simon Wing Fai Mok, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8

Immediate myeloid depot for SARS-CoV-2 in the human lung
Mélia Magnen, Ran You, Arjun A. Rao, et al.
Science Advances (2024) Vol. 10, Iss. 31
Open Access | Times Cited: 5

A Novel In Vitro Primary Human Alveolar Model (AlveolAir™) for H1N1 and SARS-CoV-2 Infection and Antiviral Screening
Cristiane Lopes, Emilie Laurent, Mireille Caul-Futy, et al.
Microorganisms (2025) Vol. 13, Iss. 3, pp. 572-572
Open Access

Aging shapes infection profiles of influenza A virus and SARS-CoV-2 in human precision-cut lung slices
Melanie Brügger, Carlos Machahua, Trix Zumkehr, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access

Toll-like receptor 7 (TLR7)-mediated antiviral response protects mice from lethal SARS-CoV-2 infection
Roshan Ghimire, Rakshya Shrestha, Radhika Amaradhi, et al.
Journal of Virology (2025)
Open Access

A Modular Mathematical Model of the Immune Response for Investigating the Pathogenesis of Infectious Diseases
Maxim I. Miroshnichenko, Fedor Kolpakov, Ilya R. Akberdin
Viruses (2025) Vol. 17, Iss. 5, pp. 589-589
Open Access

A survey of SARS-CoV-2 tropism
Xiangxing Jin, Xiang Ren, Xianwen Ren, et al.
Infectious Diseases & Immunity (2025)
Open Access

Overreactive macrophages in SARS-CoV-2 infection: The effects of ACEI
Dominik Felkle, Katarzyna Zięba, Konrad Kaleta, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110858-110858
Open Access | Times Cited: 9

Intrinsic Factors Behind the Long‐COVID: V. Immunometabolic Disorders
Muhamed Adilović, Altijana Hromić‐Jahjefendić, Lejla Mahmutović, et al.
Journal of Cellular Biochemistry (2024)
Closed Access | Times Cited: 3

Severe COVID-19versusmultisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection
Rupsha Fraser, Aurelio Orta‐Resendiz, David H. Dockrell, et al.
European Respiratory Review (2023) Vol. 32, Iss. 167, pp. 220197-220197
Open Access | Times Cited: 7

Development trends of human organoid‐based COVID‐19 research based on bibliometric analysis
Minghui Li, Yuhong Yuan, Ting Zou, et al.
Cell Proliferation (2023) Vol. 56, Iss. 12
Open Access | Times Cited: 7

Ex vivo infection model for Francisella using human lung tissue
Kristin Köppen, Diana Fatykhova, Gudrun Holland, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 7

Protective role of the HSP90 inhibitor, STA-9090, in lungs of SARS-CoV-2-infected Syrian golden hamsters
Luiz Gustavo Teixeira Alves, Morris Baumgardt, Christine Langner, et al.
BMJ Open Respiratory Research (2024) Vol. 11, Iss. 1, pp. e001762-e001762
Open Access | Times Cited: 2

Does autonomous macrophage-driven inflammation promote alveolar damage in COVID-19?
David H. Dockrell, Clark D Russell, Brian J. McHugh, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 6, pp. 2201521-2201521
Open Access | Times Cited: 8

Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection
Jane Shaw, Stephanus T. Malherbe, Gerhard Walzl, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4

Comparable CD8+ T‐cell responses to SARS‐CoV‐2 vaccination in single‐cell transcriptomics of recently allogeneic transplanted patients and healthy individuals
Eva Tranter, Marco Frentsch, Marie Luise Hütter‐Krönke, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top